Archives
-
Lipid Ratio Optimization in mRNA Nanoparticles
2026-09-30
This study compares one-factor-at-a-time and Design of Experiments strategies for optimizing lipid molar ratios in mRNA lipid nanoparticles. Its results show that conventional ratios are robust but not necessarily optimal, while manufacturing mode can alter the relationship between composition, particle quality, and biological expression.
-
Multiplexed CRISPR–Cas for Genome Engineering
2026-09-30
This 2025 review explains how multiplexed CRISPR–Cas expands genome engineering from single-locus disruption to coordinated deletions, structural-variant formation, multi-gene regulation, epigenome editing, and selective cellular damage. Its practical value lies in framing guide design, delivery, repair outcomes, and toxicity as linked variables that must be evaluated together.
-
TaqI Restriction Endonuclease: Practical DNA Digestion
2026-09-29
TaqI Restriction Endonuclease provides sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA, with a product-stated digestion interval of 5–15 minutes. It is appropriate for research workflows involving the recognition site 5′…T↓CGA…3′, but it should not be used for diagnostic or medical applications, and reaction conditions must be verified against the current product instructions.
-
MEK/ERK Signaling in Murine Lupus Lung Hemorrhage
2026-09-29
This preprint identifies MEK1/2–ERK1/2 activation as a key driver of endothelial injury, altered hemostasis, and diffuse alveolar hemorrhage in pristane-induced lupus in susceptible B6 mice. Its inhibitor-based design distinguishes this pathway from JNK and p38 signaling and links ERK activity to Egr1 expression, tissue-factor balance, thrombomodulin release, and bleeding.
-
Plasmid Prep as a Lever in AML Translation
2026-09-28
A mechanistic and strategic guide to using reproducible plasmid preparation in AML studies of the LMO2/LDB1 regulatory axis, with practical guidance for cloning, sequencing, perturbation, rescue, and transfection workflows.
-
HyperScript III RT SuperMix for CRC qPCR
2026-09-28
Turn colorectal cancer transcriptome findings into a practical RT-qPCR validation workflow for CLCA1, UGT2A3, and ZG16. HyperScript III RT SuperMix combines pre-RT genomic DNA cleanup with cDNA synthesis designed for low-input and GC-rich RNA, while assay controls and careful interpretation help keep biomarker claims appropriately grounded.
-
Separating RNA–LNP Therapeutics: Methods and Challenges
2026-09-27
Drennan and Schug review why batch assays alone can be insufficient for characterizing heterogeneous RNA–lipid nanoparticle (LNP) medicines, and assess separation-based approaches for analyzing RNA, particles, and their complexes. Their central practical message is that complementary methods are needed to connect composition, particle properties, and RNA association for more reliable characterization and quality control.
-
HyperScript III RT SuperMix in CRC qPCR
2026-09-26
Translate colorectal cancer subtype findings into a practical RT-qPCR validation workflow with integrated genomic DNA cleanup. HyperScript III RT SuperMix supports assays across low-input and high-GC RNA, while careful controls keep exploratory biomarker measurements distinct from clinical conclusions.
-
From OVA mRNA to More Interpretable Immune Models
2026-09-25
A delivery-aware framework for using EZ Cap™ OVA mRNA to study antigen expression and immune responses—while separating transcript quality from formulation effects and inflammatory signals.
-
Cell Counting Kit-8 for SYT7 Tumor Research
2026-09-25
Use CCK-8 to quantify viable-cell responses when testing how G-quadruplex ligands affect SYT7-linked tumor growth. This practical guide connects the assay’s WST-8 chemistry to plate-based workflows, controls, and interpretation limits—without treating metabolic signal as a direct measure of gene expression.
-
ML-Guided LNPs for Microglial mRNA Immunomodulation
2026-09-24
Rafiei, Shojaei, and Chau used supervised machine learning to connect lipid nanoparticle design with mRNA transfection and microglial phenotype, screening 216 formulations across resting and activated BV-2 cells. Their strongest model supported selection of an HA-modified formulation that delivered IL-10 mRNA and reduced inflammatory readouts, with follow-up evidence in human iPSC-derived microglia; the results are promising but remain preclinical.
-
CDK9 inhibitor (A3294): Practical Lab Guide
2026-09-24
CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for investigating CDK9-dependent transcription elongation and P-TEFb-related processes. It is suited to focused biochemical or cell-based work, including MT4 HIV-1 research, but not broad-spectrum CDK inhibition or workflows requiring long-term storage of prepared solutions.
-
Self-Amplifying RNA Improves Influenza B Vaccine Protection
2026-09-23
A mouse study compared nucleoside-modified mRNA, self-amplifying RNA (saRNA), and circular RNA vaccine approaches after optimizing influenza hemagglutinin sequences. At a reported 0.1 μg dose, trivalent saRNA produced durable antibody responses and complete protection against influenza B challenge, highlighting a platform-specific dose-sparing result that still requires validation beyond animal models.
-
SAFB, Satellite RNAs, and Heterochromatin Phase Separation
2026-09-23
Huo et al. identify SAFB and major satellite RNAs as cooperating regulators of pericentromeric heterochromatin architecture, linking RNA binding to phase-separation behavior and genome-wide structural organization. Their findings provide a mechanistic framework for understanding how nuclear matrix proteins and repeat transcripts stabilize higher-order chromatin, while also defining important limits for translating condensate observations into functional genome models.
-
L. gasseri Protects the Colonic Barrier via NR1I3
2026-09-22
Qian et al. show that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by preserving E-cadherin-dependent epithelial barrier function. The study links probiotic activity to NR1I3-mediated regulation of CDH1 transcription and provides a mechanistic framework for investigating strain-specific interventions in intestinal inflammation.